1 Department of Respiratory Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Am J Respir Cell Mol Biol. 2014 Apr;50(4):723-36. doi: 10.1165/rcmb.2012-0451OC.
Accumulating evidence has demonstrated that up-regulation of the angiotensin (Ang)-converting enzyme (ACE)/AngII/AngII type 1 receptor (AT1R) axis aggravates pulmonary fibrosis. The recently discovered ACE2/Ang-(1-7)/Mas axis, which counteracts the activity of the ACE/AngII/AT1R axis, has been shown to protect against pulmonary fibrosis. However, the mechanisms by which ACE2 and Ang-(1-7) attenuate pulmonary fibrosis remain unclear. We hypothesized that up-regulation of the ACE2/Ang-(1-7)/Mas axis protects against bleomycin (BLM)-induced pulmonary fibrosis by inhibiting the mitogen-activated protein kinase (MAPK)/NF-κB pathway. In vivo, Ang-(1-7) was continuously infused into Wistar rats that had received BLM or AngII. In vitro, human fetal lung-1 cells were pretreated with compounds that block the activities of AT1R, Mas (A-779), and MAPKs before exposure to AngII or Ang-(1-7). The human fetal lung-1 cells were infected with lentivirus-mediated ACE2 before exposure to AngII. In vivo, Ang-(1-7) prevented BLM-induced lung fibrosis and AngII-induced lung inflammation by inhibiting the MAPK phosphorylation and NF-κB signaling cascades. However, exogenous Ang-(1-7) alone clearly promoted lung inflammation. In vitro, Ang-(1-7) and lentivirus-mediated ACE2 inhibited the AngII-induced MAPK/NF-κB pathway, thereby attenuating inflammation and α-collagen I production, which could be reversed by the Mas inhibitor, A-779. Ang-(1-7) inhibited AngII-induced lung fibroblast apoptotic resistance via inhibition of the MAPK/NF-κB pathway and activation of the BCL-2-associated X protein/caspase-dependent mitochondrial apoptotic pathway. Ang-(1-7) alone markedly stimulated extracellular signal-regulated protein kinase 1/2 phosphorylation and the NF-κB cascade. Up-regulation of the ACE2/Ang-(1-7)/Mas axis protected against pulmonary fibrosis by inhibiting the MAPK/NF-κB pathway. However, close attention should be paid to the proinflammatory effects of Ang-(1-7).
越来越多的证据表明,血管紧张素转换酶(ACE)/血管紧张素 II(AngII)/血管紧张素 II 型 1 型受体(AT1R)轴的上调可加重肺纤维化。最近发现的 ACE2/Ang-(1-7)/Mas 轴可拮抗 ACE/AngII/AT1R 轴的活性,已被证明可预防肺纤维化。然而,ACE2 和 Ang-(1-7)减轻肺纤维化的机制尚不清楚。我们假设 ACE2/Ang-(1-7)/Mas 轴的上调通过抑制丝裂原活化蛋白激酶(MAPK)/核因子-κB 通路来预防博来霉素(BLM)诱导的肺纤维化。在体内,持续向接受 BLM 或 AngII 的 Wistar 大鼠输注 Ang-(1-7)。在体外,用人胎肺-1 细胞预处理可阻断 AT1R、Mas(A-779)和 MAPKs 活性的化合物,然后暴露于 AngII 或 Ang-(1-7)。用人胎肺-1 细胞感染 ACE2 慢病毒后再暴露于 AngII。在体内,Ang-(1-7)通过抑制 MAPK 磷酸化和 NF-κB 信号级联来预防 BLM 诱导的肺纤维化和 AngII 诱导的肺炎症。然而,外源性 Ang-(1-7)本身显然会促进肺炎症。在体外,Ang-(1-7)和慢病毒介导的 ACE2 抑制 AngII 诱导的 MAPK/NF-κB 通路,从而减轻炎症和 α-胶原蛋白 I 的产生,而 Mas 抑制剂 A-779 可逆转这一作用。Ang-(1-7)通过抑制 MAPK/NF-κB 通路和激活 BCL-2 相关 X 蛋白/半胱天冬酶依赖性线粒体凋亡途径来抑制 AngII 诱导的肺成纤维细胞凋亡抵抗。Ang-(1-7)本身可显著刺激细胞外信号调节蛋白激酶 1/2 磷酸化和 NF-κB 级联。ACE2/Ang-(1-7)/Mas 轴的上调通过抑制 MAPK/NF-κB 通路来预防肺纤维化。然而,应密切关注 Ang-(1-7)的促炎作用。